SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-013600
Filing Date
2020-03-27
Accepted
2020-03-27 16:08:06
Documents
6
Period of Report
2020-03-27

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200327.htm 6-K 22711
2 EX-99.1 lmnl-ex991_6.htm EX-99.1 5416392
3 GRAPHIC gy3v4kutyuwu000004.jpg GRAPHIC 7615
4 GRAPHIC gy3v4kutyuwu000001.jpg GRAPHIC 12047
5 GRAPHIC gy3v4kutyuwu000002.jpg GRAPHIC 7615
6 GRAPHIC gy3v4kutyuwu000003.jpg GRAPHIC 5273
  Complete submission text file 0001564590-20-013600.txt   5485667
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 20751848
SIC: 2834 Pharmaceutical Preparations